Publisher： Bentham Science Publishers
E-ISSN： 1875-6913|12|3|176-181
ISSN： 1875-6921
Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.12, Iss.3, 2015-03, pp. : 176-181
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules
Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. :
Access to resources
Recommend
Immuno-Isolation in Oncology - A Mini-Review
Current Pharmaceutical Biotechnology, Vol. 2, Iss. 3, 2001-09 ,pp. :
From ImmunoToxins to ImmunoRNases
Current Pharmaceutical Biotechnology, Vol. 9, Iss. 3, 2008-06 ,pp. :
Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-01 ,pp. :